NanoViricides, Inc. Reports That Its Director Dr. Milton Boniuk, A Director, Has Invested $5M Into The Company In A Convertible Debenture

Published: Jul 02, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (NYSE MKT:NNVC) (the “Company”) reported today that Milton Boniuk, MD, the Caroline F. Elles Chair Professor of Ophthalmology at Baylor College of Medicine, and a Director of the Company, has invested $5M in the Company in the form of a convertible debenture (the “Debenture”).

Help employers find you! Check out all the jobs and post your resume.

Back to news